[
  {
    "title": "Big Bank earnings, March housing data: What to Watch",
    "published": 1713213981,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Q1 '24 S&P 500 Earnings (And Johnson & Johnson): Expecting Another Normal Earnings Season",
    "published": 1713213300,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "WHO warns of falsified cough syrup ingredients seized in Pakistan",
    "published": 1713207100,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Sysco And Grainger Among 10 Companies To Announce Annual Dividend Increases In Second Half Of April",
    "published": 1713200870,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "NEW YORK MARKET CLOSE: Dow hit by hot retail sales, Middle East nerves",
    "published": 1713197820,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Johnson & Johnson Reports Earnings Tuesday. What to Expect.",
    "published": 1713192000,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "3 Blue Chip Stocks For Your April 2024 Watchlist",
    "published": 1713191020,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?",
    "published": 1713189960,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "UPDATE 3-Tanzania, Rwanda, Zimbabwe join African recall of J&J cough syrup",
    "published": 1713189325,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "MEDIA-Zimbabwe recalls tainted J&J's cough syrup sold in six African nations- Bloomberg News",
    "published": 1713187696,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results",
    "published": 1713185580,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "5 U.S. Bigwigs Likely to Gain on Q1 Earnings Beat This Week",
    "published": 1713183540,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Notable companies reporting before tomorrow\u00e2\ufffd\ufffd\ufffd\ufffds open",
    "published": 1713182280,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Notable earnings before Tuesday's open",
    "published": 1713179640,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Rwanda joins other African countries in recalling J&J children's cough syrup",
    "published": 1713178220,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Tanzania and Rwanda join its African counterparts to recall J&J's cough syrup - report",
    "published": 1713177540,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)",
    "published": 1713163560,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Wall Street Breakfast Podcast: Samsung Overtakes Apple As Top Smartphone Maker",
    "published": 1713163267,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value",
    "published": 1713160860,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Options Volatility and Implied Earnings Moves This Week, April 15 \u2013 April 19, 2024",
    "published": 1713160860,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Mind Medicine initiated with bullish view at Leerink, here's why",
    "published": 1713158940,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Integer just upgraded at BofA, here's why",
    "published": 1713157740,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play",
    "published": 1713153120,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash",
    "published": 1713081840,
    "posting_price": 143.75811871,
    "close_price": 143.00236511,
    "percent_change": -0.52571194
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1713081061,
    "posting_price": 143.75811871,
    "close_price": 143.00236511,
    "percent_change": -0.52571194
  },
  {
    "title": "Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",
    "published": 1713078360,
    "posting_price": 143.75811871,
    "close_price": 143.00236511,
    "percent_change": -0.52571194
  },
  {
    "title": "UPDATE 1-South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity",
    "published": 1713050595,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity",
    "published": 1713034073,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "J&J cough syrup recall classified as most serious in South Africa",
    "published": 1712977140,
    "posting_price": 143.75813405,
    "close_price": 143.00238037,
    "percent_change": -0.52571194
  },
  {
    "title": "Johnson & Johnson (JNJ) Stock Moves -0.85%: What You Should Know",
    "published": 1712958320,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Bank earnings, housing, Trump trial: What to Watch Next Week",
    "published": 1712954695,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "3 Quarterly Releases to Watch Next Week",
    "published": 1712948400,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "55 April Dividend Kings: Buy 8, Watch 8",
    "published": 1712932765,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?",
    "published": 1712927340,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Buy/Sell: Wall Street's top 10 stock calls this week",
    "published": 1712925480,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",
    "published": 1712924520,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Major banks deliver EPS beat this week to kick off Q1 earnings; JPMorgan FY interest margin guidance unchanged - Earnings Scorecard",
    "published": 1712923380,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "5 Dividend Kings That Yield More Than Vanguard's Top Value ETF",
    "published": 1712923200,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Global company events calendar",
    "published": 1712918340,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet",
    "published": 1712917980,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Johnson & Johnson - Unique molecular properties of nipocalimab enabling differentiated potential in treating generalized myasthenia gravis to be presented at American Academy of Neurology's 2024 Annual Meeting",
    "published": 1712910040,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow",
    "published": 1712908800,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Healthpeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth",
    "published": 1712905200,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map",
    "published": 1712898708,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Stock market today: Wall Street falls sharply to close out its worst week since October",
    "published": 1712893740,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "NAFDAC Raises Alarm Over Fake Anti-Bacteria Injection, Deadly Cough Syrup",
    "published": 1712891174,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Kenya, Nigeria Recall Children's Cough Syrup Over Toxic Substance",
    "published": 1712887569,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",
    "published": 1712887200,
    "posting_price": 143.45776342,
    "close_price": 142.93455505,
    "percent_change": -0.36471248
  },
  {
    "title": "UPDATE 1-Kenya recalls J&J children's cough syrup over suspected toxicity",
    "published": 1712858752,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Kenya recalls J&J children's cough syrup over suspected toxicity",
    "published": 1712844645,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Unlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics",
    "published": 1712841316,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
    "published": 1712840414,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024",
    "published": 1712837640,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Dow's 100-point drop led by losses in shares of Travelers, Chevron",
    "published": 1712836020,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "All-Time High Flyers: 7 Stocks to Buy as the Market Peaks",
    "published": 1712834520,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "J&J: presents results on nipocalimab",
    "published": 1712831845,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "May 31st Options Now Available For Johnson & Johnson (JNJ)",
    "published": 1712828520,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Kenvue's performance has been 'woeful' with 'worst-in-class' growth - analyst",
    "published": 1712827260,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "5 Things To Know In Investing This Week - The Shockwave Takeover Issue",
    "published": 1712826360,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today",
    "published": 1712825520,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "DoorDash upgraded, Airbnb downgraded: Wall Street's top analyst calls",
    "published": 1712824860,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Alkermes' Innovations Are Transforming Mental Health Treatments",
    "published": 1712822460,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Johnson & Johnson Q1 Earnings Preview: Shockwave Could Be A Good Fit Despite Headwinds",
    "published": 1712820631,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Rallybio price target lowered by $2 at Wedbush, here's why",
    "published": 1712819820,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Why Is Rallybio (RLYB) Stock Up 93% Today?",
    "published": 1712817960,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Today\u2019s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on\u00a0Thursday",
    "published": 1712816640,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Rallybio shares gain on investment from J&J for rare fetal condition treatment",
    "published": 1712815320,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "Joby\u2019s $3.5B Air Taxi Dream Worth Less Than Trump\u2019s Truth Social Nightmare?",
    "published": 1712814840,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "10 Attractive sell puts within the Russell 1000 - JPM",
    "published": 1712798520,
    "posting_price": 146.11260107,
    "close_price": 144.16506958,
    "percent_change": -1.33289769
  },
  {
    "title": "J&J, Rallybio partner on drug development for rare fetal condition",
    "published": 1712768460,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "The Pharmaceutical Industry Finds Itself At A Historical Crossroads",
    "published": 1712767671,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Nigeria recalls J&J children's cough syrup over toxic substance",
    "published": 1712763818,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "What's in Store for Dow ETFs in Q1 Earnings?",
    "published": 1712761800,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "published": 1712754010,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape",
    "published": 1712751840,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly",
    "published": 1712750443,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), PainReform (PRFX) and IN8bio (INAB)",
    "published": 1712749800,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Johnson & Johnson Enters Oversold Territory",
    "published": 1712748720,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)",
    "published": 1712747460,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?",
    "published": 1712739420,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)",
    "published": 1712738760,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Maintaining Stability Amidst Challenges: Hold Rating for Johnson & Johnson",
    "published": 1712736540,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names",
    "published": 1712727060,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024",
    "published": 1712724600,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "published": 1712720100,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Kenvue initiated with bearish view at Bernstein, here's why",
    "published": 1712719380,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Rallybio to partner with J&J on soultions to reduce risk of FNAIT",
    "published": 1712718180,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Johnson & Johnson cough syrup recalled in Nigeria over toxicity concerns",
    "published": 1712716380,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Axsome Therapeutics (AXSM) and Premier (PINC)",
    "published": 1712712060,
    "posting_price": 146.81989528,
    "close_price": 145.53123474,
    "percent_change": -0.8777152
  },
  {
    "title": "Neutrogena Closing Its Los Angeles Headquarters to Move to New\u00a0Jersey",
    "published": 1712693286,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?",
    "published": 1712671216,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "How's AT&T Handling Things?",
    "published": 1712670666,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1712666400,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "Oakmark Fund: First Calendar Quarter 2024 Commentary",
    "published": 1712655600,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade",
    "published": 1712650860,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "Kenvue cutting Neutrogena jobs, closing LA office - report",
    "published": 1712647680,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "Johnson and Johnson traded in the green after six day of losses",
    "published": 1712632620,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Johnson & Johnson",
    "published": 1712624760,
    "posting_price": 146.83928573,
    "close_price": 147.55627441,
    "percent_change": 0.48828124
  },
  {
    "title": "Here's Why Johnson & Johnson (JNJ) Fell More Than Broader Market",
    "published": 1712613021,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference",
    "published": 1712599625,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Kenvue Revamps Cyber Tools After Spinoff From J&J",
    "published": 1712591520,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "VOOV: A Decent Passively Managed Value ETF, But Not The Best",
    "published": 1712588993,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma",
    "published": 1712583600,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio",
    "published": 1712582280,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says",
    "published": 1712579280,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "J&J: presents results on anticoagulant",
    "published": 1712573730,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "March 2024 Passive Income - More Money",
    "published": 1712572200,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Ulta upgraded, Skyworks downgraded: Wall Street's top analyst calls",
    "published": 1712565900,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "2 Dividend Stocks to Buy and Hold Forever",
    "published": 1712562360,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson to Acquire Shockwave Medical",
    "published": 1712561311,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson - CARVYKTI is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy",
    "published": 1712561230,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "ShockWave Medical just downgraded at Needham, here's why",
    "published": 1712558280,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson announces presentation of findings on XARELTO",
    "published": 1712556240,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "ShockWave Medical just downgraded at Deutsche Bank, here's why",
    "published": 1712547600,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population",
    "published": 1712539320,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Here's the $4.7 Trillion Market Nvidia Has Its Eyes on Now",
    "published": 1712514600,
    "posting_price": 147.26561194,
    "close_price": 146.8780365,
    "percent_change": -0.26318122
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540,
    "posting_price": 147.26561194,
    "close_price": 146.8780365,
    "percent_change": -0.26318122
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180,
    "posting_price": 147.26561194,
    "close_price": 146.8780365,
    "percent_change": -0.26318122
  },
  {
    "title": "FDA approves J&J's CARVYKTI in refractory multiple myeloma",
    "published": 1712467320,
    "posting_price": 147.26561194,
    "close_price": 146.8780365,
    "percent_change": -0.26318122
  },
  {
    "title": "Can a New CEO Fix Boeing?",
    "published": 1712405700,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Grow Your Bottom Line As Demand Increases For These Robots",
    "published": 1712402400,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "5 Relatively Secure And Cheap Dividend Stocks To Invest In - April 2024",
    "published": 1712395800,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Johnson & Johnson wins FDA nod for Carvykti label expansion",
    "published": 1712389260,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "U.S. IPO Weekly Recap: April IPO Market Gets A Boost From Large Launches And New Filings",
    "published": 1712382600,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "CARVYKTI\u00ae is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy",
    "published": 1712373660,
    "posting_price": 147.26559664,
    "close_price": 146.87802124,
    "percent_change": -0.26318122
  },
  {
    "title": "Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?",
    "published": 1712345220,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Stocks Soar After Robust Jobs Data; AMD, Amazon.com Lead Tech Rally, But Tesla Sinks On This News",
    "published": 1712337041,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "NEW YORK MARKET CLOSE: Blow-out jobs figures back soft landing hopes",
    "published": 1712333820,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review",
    "published": 1712331917,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.",
    "published": 1712328968,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson Ends The Shockwave Rumor Mill With $13.1 Billion Takeover",
    "published": 1712325923,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "4 Dividend Aristocrats Signal Buy In April Plus 6 To Watch",
    "published": 1712324215,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "J&J to pump another $13B into its MedTech business with Shockwave deal",
    "published": 1712321786,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion",
    "published": 1712321723,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal",
    "published": 1712320680,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Newmont, Shockwave Medical rise; John Bean falls, Friday, 4/4/2024",
    "published": 1712319900,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Newmont, Shockwave Medical rise; John Bean fall, Friday, 4/4/2024",
    "published": 1712319900,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Contineum Therapeutics stock slides 10% following $110M IPO",
    "published": 1712319840,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Institutional owners may consider drastic measures as Johnson & Johnson's (NYSE:JNJ) recent US$14b drop adds to long-term losses",
    "published": 1712318482,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion. It\u2019s a Cardio Health Play.",
    "published": 1712315760,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson Acquires ShockWave Medical in a Strategic $13 Billion Deal",
    "published": 1712315700,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1712315040,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "J&J to acquire Shockwave Medical in $13.1 billion deal that will boost its heart-disease medtech portfolio",
    "published": 1712313720,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "UPDATE 4-J&J boosts heart device business with $12.5 bln Shockwave Medical deal",
    "published": 1712313667,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "J&J boosts heart device business with $12.5 billion Shockwave Medical deal",
    "published": 1712313540,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to Showcase its Broad Scientific Leadership and Latest Innovations to Combat Cardiovascular Disease at ACC.24",
    "published": 1712311009,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery",
    "published": 1712311006,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to acquire Shockwave Medical for $13.1B (update)",
    "published": 1712307960,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "J&J to acquire Shockwave Medical for $13.1B",
    "published": 1712306563,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson",
    "published": 1712306100,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "M&A News: Johnson & Johnson (NYSE:JNJ) Enters Into $13.1B Shockwave Medical Deal",
    "published": 1712305920,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "4 stocks to watch on Friday: SWAV on JNJ deal, NFLX and more",
    "published": 1712304840,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical",
    "published": 1712302740,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "J&J: agreement to acquire Shockwave Medical",
    "published": 1712302469,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Morning Brew: Johnson & Johnson Acquires Shockwave Medical in $13.1B Deal",
    "published": 1712302320,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal that will boost its heart-disease medtech portfolio",
    "published": 1712301300,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "TOP NEWS: J&J swoops for Shockwave Medical in USD13.1 billion deal",
    "published": 1712300520,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to acquire Shockwave Medical for $13.1B in cash",
    "published": 1712296800,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson: ShockWave Medical deal to accelerate revenue growth",
    "published": 1712295540,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson sees ShockWave Medical deal dilutive to EPS in FY24/FY25",
    "published": 1712295360,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson to acquire ShockWave Medical for $335.00 per share in cash",
    "published": 1712295240,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Stock market today: Wall Street gains ground following surprisingly strong US jobs report",
    "published": 1712289180,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024",
    "published": 1712288220,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "IN BRIEF: J&J cautions shareholders against discount tender offer",
    "published": 1712287020,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "What You Missed On Wall Street On Friday",
    "published": 1712286480,
    "posting_price": 147.30434201,
    "close_price": 147.65315247,
    "percent_change": 0.23679578
  },
  {
    "title": "Johnson & Johnson Recommends Shareholders Reject \"Mini-Tender\" Offer by TRC Capital Investment Corporation",
    "published": 1712268060,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Johnson & Johnson Recommends Shareholders Reject \u201cMini-Tender\u201d Offer by TRC Capital Investment Corporation",
    "published": 1712253660,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Strategic Allocation For A $100,000 Dividend Income Portfolio With A Sustainable Dividend Yield",
    "published": 1712253600,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment",
    "published": 1712253336,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Johnson & Johnson: Self-Proclaimed 'Dividend King' Faces Tricky Outlook",
    "published": 1712238334,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "FDA approves new antibiotic for several hard-to-treat infections",
    "published": 1712230200,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Time to Tap Healthcare ETFs on Nvidia's AI Ambition?",
    "published": 1712228400,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Interesting JNJ Put And Call Options For May 24th",
    "published": 1712223360,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender",
    "published": 1712216700,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "ShockWave Medical just downgraded at Wolfe Research, here's why",
    "published": 1712211120,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Odyssey Therapeutics enters into a collaboration with Jannsen Pharmaceutica",
    "published": 1712210520,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Johnson & Johnson urges shareholders to reject 'mini-tender' offer by TRC",
    "published": 1712206920,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.",
    "published": 1712206800,
    "posting_price": 150.48240307,
    "close_price": 147.75975037,
    "percent_change": -1.80928311
  },
  {
    "title": "Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?",
    "published": 1712160614,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "Johnson & Johnson CIO says employee upskilling is key to transforming health care",
    "published": 1712157159,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "published": 1712149211,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "April Dogs Of The Dow: Buy 1, Watch 4",
    "published": 1712143729,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "5 Things to Know in Investing This Week",
    "published": 1712136420,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "J&J: working for greater health equity in the USA",
    "published": 1712135975,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows",
    "published": 1712130660,
    "posting_price": 152.8853003,
    "close_price": 149.46502686,
    "percent_change": -2.23714996
  },
  {
    "title": "Johnson & Johnson (JNJ) Stock Moves -0.03%: What You Should Know",
    "published": 1712094321,
    "posting_price": 151.70324717,
    "close_price": 152.82717896,
    "percent_change": 0.74087524
  },
  {
    "title": "Johnson & Johnson to Participate in the BofA Securities Health Care Conference",
    "published": 1712075586,
    "posting_price": 151.70324717,
    "close_price": 152.82717896,
    "percent_change": 0.74087524
  },
  {
    "title": "12 Dividend Increases Expected In April 2024",
    "published": 1712065246,
    "posting_price": 151.70324717,
    "close_price": 152.82717896,
    "percent_change": 0.74087524
  },
  {
    "title": "11 Dividend Increases Expected In April 2024",
    "published": 1712021220,
    "posting_price": 151.70324717,
    "close_price": 152.82717896,
    "percent_change": 0.74087524
  },
  {
    "title": "Russell 2000 Index Best And Worst Performing Stocks Of 2024",
    "published": 1712020200,
    "posting_price": 151.70324717,
    "close_price": 152.82717896,
    "percent_change": 0.74087524
  },
  {
    "title": "Stifel, Morgan Stanley bullish on newly public Contineum",
    "published": 1714479300,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "Addex stock tanks after lead drug flops in Phase II epilepsy trial",
    "published": 1714471302,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "FTC expands patent listing challenges for drugs",
    "published": 1714468440,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",
    "published": 1714467180,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "Stock Market Crash Warning: Don\u2019t Get Caught Holding These 3 Healthcare Stocks",
    "published": 1714466820,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn",
    "published": 1714458120,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "7 Dividend Aristocrats Paying Sky-High Yields: April 2024",
    "published": 1714447980,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity",
    "published": 1714441920,
    "posting_price": 142.31445379,
    "close_price": 140.09562683,
    "percent_change": -1.55910162
  },
  {
    "title": "J&J, Bristol Myers lose challenges to US drug price negotiation program",
    "published": 1714427556,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks",
    "published": 1714409631,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Johnson & Johnson Is a King of Dividend Safety",
    "published": 1714400580,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Addex stock plunges 50% on failed study for epilepsy drug",
    "published": 1714388880,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?",
    "published": 1714388514,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "J&J: positive CHMP opinion for lung cancer",
    "published": 1714386859,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "EU regulators recommend full approval for J&J TB drug Sirturo",
    "published": 1714386060,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "J&J receives positive CHMP opinion recommending approval of Sirturo in MDR TB",
    "published": 1714382460,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "7 Retirement Stocks to Buy at a 52-Week Low in April",
    "published": 1714381500,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May",
    "published": 1714379505,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value",
    "published": 1714370460,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Cutting Edge Picks: 3 Med Tech Stocks With Room to Run",
    "published": 1714363860,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Johnson & Johnson stock outperforms competitors on strong trading day",
    "published": 1714361700,
    "posting_price": 141.59744628,
    "close_price": 142.25631714,
    "percent_change": 0.46531267
  },
  {
    "title": "Dividend Stock Portfolio For Income: Top 15 Stocks",
    "published": 1714344883,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "2 Top Growth Stocks to Buy Right Now and Hold Forever",
    "published": 1714308300,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",
    "published": 1714305840,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "Better Dividend Stock: AbbVie or Johnson & Johnson?",
    "published": 1714292400,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates",
    "published": 1714273200,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "10 Best Long Term Low Risk Stocks to Buy",
    "published": 1714223746,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "Johnson & Johnson Stock: Buy, Sell, or Hold?",
    "published": 1714218300,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "7 Stocks to Buy if Inflation Continues to Reign in 2024",
    "published": 1714196580,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "Generational Wealth Builders: 3 Stocks to Own for Decades of Gains",
    "published": 1714194420,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "What Investing Account Types Are The Best Fit For You And Your Dividends?",
    "published": 1714188780,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "5 Stocks In Focus On Their Recent Dividend Hikes",
    "published": 1714185600,
    "posting_price": 141.59743109,
    "close_price": 142.25630188,
    "percent_change": 0.46531267
  },
  {
    "title": "AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View",
    "published": 1714147800,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "Are You Looking for a High-Growth Dividend Stock?",
    "published": 1714146309,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "5 Stocks in Focus on Their Recent Dividend Hike",
    "published": 1714133580,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "Johnson & Johnson : receives positive CHMP opinion for RYBREVANT\u00ae\u25bc (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations",
    "published": 1714131902,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?",
    "published": 1714108020,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April",
    "published": 1714107720,
    "posting_price": 142.14001813,
    "close_price": 141.59742737,
    "percent_change": -0.38172977
  },
  {
    "title": "Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data",
    "published": 1714069724,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)",
    "published": 1714067356,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "Cidara buys back rights to flu therapy from J&J for $85m",
    "published": 1714062173,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "Bert's March Dividend Income Summary",
    "published": 1714052100,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24",
    "published": 1714044997,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?",
    "published": 1714040280,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys",
    "published": 1714032600,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "7 blue chip stocks to Buy on the Dip: April 2024",
    "published": 1714024380,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "US Stock: Johnson & Johnson",
    "published": 1714023900,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024",
    "published": 1714021560,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "The Top 3 Small-Cap Stocks to Buy in April 2024",
    "published": 1714010820,
    "posting_price": 144.7270422,
    "close_price": 142.25631714,
    "percent_change": -1.70716199
  },
  {
    "title": "Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?",
    "published": 1713981480,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson",
    "published": 1713963000,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth",
    "published": 1713957900,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Neurocrine Biosciences upgraded at Wells Fargo on pipeline",
    "published": 1713956640,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar",
    "published": 1713955200,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "LLY vs. JNJ: Which Big Pharma Stock Is Better?",
    "published": 1713954240,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years",
    "published": 1713953400,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Video: Dow Movers: JNJ, BA",
    "published": 1713952200,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever",
    "published": 1713950700,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "14 Dividend Growth Stocks with Highest Growth Rates",
    "published": 1713942152,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "March Readers Marked 20 Ideal-To-Buy Dividend Dogs",
    "published": 1713938963,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Johnson & Johnson Stocks Elliott Wave Technical Analysis",
    "published": 1713937020,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Cidara stock rallies amid $240M private placement, drug update",
    "published": 1713930540,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M",
    "published": 1713928380,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Welfare Plan Class Action Litigation Underscores Importance Of Minding Your Fiduciary Duties",
    "published": 1713925153,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "Johnson & Johnson management to meet with Oppenheimer",
    "published": 1713921840,
    "posting_price": 143.53527018,
    "close_price": 143.91314697,
    "percent_change": 0.26326407
  },
  {
    "title": "4 Stocks to Watch on Their Recent Dividend Hikes",
    "published": 1713876120,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Sanofi reportedly lining up banks for consumer products spinoff",
    "published": 1713875640,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Johnson & Johnson to participate in the Bernstein's 40th Annual Strategic Decisions Conference",
    "published": 1713866929,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Janssen - CARVYKTI is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy",
    "published": 1713866861,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Baron Health Care Fund Q1 2024 Shareholder Letter",
    "published": 1713864600,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Takeda Pharmaceutical: A Long-Term Cash Cow",
    "published": 1713859260,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably",
    "published": 1713855620,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns",
    "published": 1713846878,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red",
    "published": 1713843180,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)",
    "published": 1713842760,
    "posting_price": 145.20181069,
    "close_price": 144.91113281,
    "percent_change": -0.20018888
  },
  {
    "title": "Johnson & Johnson to Participate in the Bernstein\u2019s 40th Annual Strategic Decisions Conference (SDC)",
    "published": 1713803647,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "10 Best Performing Biotech ETFs in 2024",
    "published": 1713798659,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "3 Dividend Stocks to Buy Now for Lifelong Income",
    "published": 1713797940,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Johnson & Johnson: Legal Woes Are Detrimental But Not Fatal",
    "published": 1713791078,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1713790816,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Legend Biotech says Carvykti approved by EC for second-line multiple myeloma",
    "published": 1713787680,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "5 Crash-Proof Stocks to Buy Immediately",
    "published": 1713787200,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "J&J: EU green light for Carvykti in multiple myeloma",
    "published": 1713782087,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "RPT-Contaminated cough syrup in Africa no longer available - WHO",
    "published": 1713778370,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "PKW: Buyback ETF Combining Value And Growth",
    "published": 1713775877,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Dividend Income Summary: Lanny's March 2024 Summary",
    "published": 1713772800,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Johnson & Johnson : CARVYKTI\u00ae\u25bc (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy",
    "published": 1713772451,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "3 Dividend Kings Down 11% You\u2019ll Regret Not Buying on the Dip",
    "published": 1713769440,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Wall Street Breakfast: Change Comes Slowly",
    "published": 1713769380,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Stryker added to 'Tactical Outperform' list at Evercore ISI",
    "published": 1713769020,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "WHO no longer planning safety alert on Kenvue cough syrup: report",
    "published": 1713749220,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "10 Stocks American Politicians are Buying in 2024",
    "published": 1713703154,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "10 Best Soaps and Cleaning Materials Stocks to Buy",
    "published": 1713698578,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Goldman picks top capex and R&D stocks",
    "published": 1713663840,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "THQ: Collecting A High Yield From Increased Medical Spending",
    "published": 1713614580,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Investing for the Long-Term: 3 Stocks With Proven Track Records",
    "published": 1713609420,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of April 21",
    "published": 1713606785,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "20 Years To $300k? Building A $10,000 Dividend Portfolio From Scratch",
    "published": 1713596400,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "10 High-Yield Dividend Aristocrats Perfect For An Uncertain Market",
    "published": 1713596400,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim",
    "published": 1713580800,
    "posting_price": 143.89376268,
    "close_price": 144.48480225,
    "percent_change": 0.41074718
  },
  {
    "title": "These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?",
    "published": 1713551420,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert",
    "published": 1713543434,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "12 Best Diversified Stocks To Invest In",
    "published": 1713538824,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Analyst updates Johnson & Johnson stock price target after earnings",
    "published": 1713538048,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "UPDATE 2-WHO likely to issue wider alert on contaminated J&J cough syrup",
    "published": 1713531020,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "WHO considering safety alert on Kenvue kids cough syrup",
    "published": 1713527640,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "WHO says wider alert on contaminated J&J cough syrup 'likely'",
    "published": 1713527277,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Mayar Capital Q1 2024 Letter To Partners",
    "published": 1713526800,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Top 12 Ultra-High Yield Dividend Stocks to Buy",
    "published": 1713525991,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Johnson & Johnson wins trial over talc-related cancer claim in Florida",
    "published": 1713524220,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges",
    "published": 1713523380,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron",
    "published": 1713520800,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "FDA Mandates \"Boxed Warning\" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies",
    "published": 1713515400,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Dividend Roundup: Johnson & Johnson, Dell, Lowe\u2019s, Qualcomm and more",
    "published": 1713511140,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Essential Pharma buys rights to J&J's Reminyl Alzheimer's treatment",
    "published": 1713506460,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk",
    "published": 1713503640,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Notches Up after Talc Lawsuit Win",
    "published": 1713496440,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Notches Up After Talc Win",
    "published": 1713494220,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",
    "published": 1713492120,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "WHO considering safety alert on Kenvue kids cough syrup (update)",
    "published": 1713491460,
    "posting_price": 141.60710636,
    "close_price": 143.31240845,
    "percent_change": 1.20424895
  },
  {
    "title": "HSBC Upgrades Johnson & Johnson (JNJ)",
    "published": 1713479842,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "US FDA mandates label updates on CAR-T cancer therapies",
    "published": 1713479589,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "J&J wins trial over Florida woman who claimed its baby powder caused her cancer",
    "published": 1713475403,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Top Stock Reports for NVIDIA, Alphabet & Johnson & Johnson",
    "published": 1713457320,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal Challenges",
    "published": 1713445020,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "14 Best Large Cap Dividend Growth Stocks To Buy Now",
    "published": 1713442555,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Recession-Proof Riches: 3 Stocks That Thrive in Any Economy",
    "published": 1713438720,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Johnson & Johnson : First Quarter 2024 2024 First-Quarter Earnings Transcript",
    "published": 1713433987,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Johnson & Johnson",
    "published": 1713432960,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.",
    "published": 1713432480,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson",
    "published": 1713430500,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Johnson & Johnson upgraded to Buy at HSBC with shares at three year lows",
    "published": 1713429840,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "HSBC gets more bullish on Johnson & Johnson, upgrades shares",
    "published": 1713428040,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amid Earnings Surprises",
    "published": 1713425520,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "Johnson & Johnson: Buy This Bargain Before It's Gone",
    "published": 1713425319,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "GLOBAL BROKER RATINGS: UBS raises Givaudan; HSBC cuts Flutter",
    "published": 1713422400,
    "posting_price": 140.47348352,
    "close_price": 141.20986938,
    "percent_change": 0.52421698
  },
  {
    "title": "JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus",
    "published": 1713362400,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Company News for Apr 17, 2024",
    "published": 1713359820,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson Insiders Sold US$6.8m Of Shares Suggesting Hesitancy",
    "published": 1713358821,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results",
    "published": 1713358620,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Q1 2024 Earnings Call Transcript",
    "published": 1713356274,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough",
    "published": 1713355020,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)",
    "published": 1713353460,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Abbott Labs Faces Downturn Post-Q1 Results Amid Mixed Sector Performances",
    "published": 1713348900,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson Reports Q1 2024 Results",
    "published": 1713347965,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase, Raises Quarterly Dividend by 4.2%",
    "published": 1713347964,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Put $10,000 in These 3 Dividend Stocks by 2025",
    "published": 1713341040,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson price target lowered by $6 at RBC Capital, here's why",
    "published": 1713340320,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday",
    "published": 1713338880,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript Highlights: Navigating Market ...",
    "published": 1713337301,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson price target lowered by $10 at BofA, here's why",
    "published": 1713331200,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI)",
    "published": 1713327660,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Scotiabank upgrades Legend Biotech to sector outperform",
    "published": 1713325200,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Kenvue: Fairly Valued Spinout",
    "published": 1713322806,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "RBC Capital Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)",
    "published": 1713322800,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future",
    "published": 1713321600,
    "posting_price": 140.49288143,
    "close_price": 140.27003479,
    "percent_change": -0.15861774
  },
  {
    "title": "Why Johnson & Johnson Stock Got Tossed by the Market Today",
    "published": 1713303900,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business",
    "published": 1713301750,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "These Stocks Moved the Most Today: UnitedHealth, DJT, Bank of America",
    "published": 1713298800,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "US STOCKS-Wall Street stocks mixed on higher Treasury yields, rate expectations",
    "published": 1713293859,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff",
    "published": 1713289757,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript",
    "published": 1713288611,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Wall Street Lunch: Bond Bulls In Hibernation",
    "published": 1713286080,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "FHLC: Healthcare Dashboard For April",
    "published": 1713284682,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "NEW YORK MARKET CLOSE: Dollar up as Powell sees no rush to lower rates",
    "published": 1713284460,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Q1 Earnings Top Wall Street Estimates On Strong Medical Devices Sales, Drugmaker Boosts Annual Outlook",
    "published": 1713281350,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Building Permits Come in Lower Than Expected",
    "published": 1713279720,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft",
    "published": 1713279180,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J CFO on Q1 Earnings, Forecast and Product Pipeline",
    "published": 1713278776,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Housing Numbers Shrink as Q1 Earnings Heat Up: BAC, JNJ, UNH",
    "published": 1713277560,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Bellwether Health Giant J&J Skids As Psoriasis Blockbuster Drags Top Line",
    "published": 1713277510,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson reports mixed Q1 earnings, narrows guidance",
    "published": 1713274989,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson (JNJ) Reports Q1 Earnings: What Key Metrics Have to Say",
    "published": 1713274210,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data",
    "published": 1713273432,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "UPDATE 2-Nigerian regulator says no record of child deaths from recalled J&J cough syrup",
    "published": 1713272116,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson\u2019s stock falls as profit beats but sales fall slightly short of estimates",
    "published": 1713271980,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Steady Performance and Aligned Guidance Justify Hold Rating for Johnson & Johnson",
    "published": 1713270960,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson (JNJ) Q1 Earnings: Aligns with EPS Projections, Reports Sales Growth",
    "published": 1713270710,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",
    "published": 1713270660,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?",
    "published": 1713270600,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Market Sentiment Wavers Amid Middle East Tensions and US Rate Speculations",
    "published": 1713269880,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Correction to Johnson & Johnson Earnings Article",
    "published": 1713269864,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "These Stocks Are Moving the Most Today: Live Nation, DJT, Tesla, UnitedHealth, J&J, Bank of America, Morgan Stanley, and More",
    "published": 1713256500,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J sees mixed performance from new multiple myeloma drugs",
    "published": 1713268260,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson (JNJ) Q1 Earnings Top Estimates",
    "published": 1713267002,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Bayer dethroned as Germany\u2019s top drugmaker",
    "published": 1713266880,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1713265320,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Stock Falls After Earnings Beat. Talc Issues Loom.",
    "published": 1713265200,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J report 'not alarming' for Legend Biotech, says H.C. Wainwright",
    "published": 1713264600,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "UPDATE 1-J&J beats first-quarter profit estimates on cancer drugs strength",
    "published": 1713263405,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%",
    "published": 1713263100,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "J&J beats first-quarter profit estimates on cancer drugs strength",
    "published": 1713262819,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson (JNJ) Q1 Earnings: Slight Gains Amid Adjusted Forecasts",
    "published": 1713262500,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Why Establish A Fiduciary Committee For Welfare Benefit Plans?",
    "published": 1713262334,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Trending : Johnson & Johnson 1Q Adjust Earnings Beat Forecasts as Company Raises Dividend",
    "published": 1713262051,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024",
    "published": 1713261180,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Video: Dow Movers: JNJ, UNH",
    "published": 1713258720,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook",
    "published": 1713256320,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson says no change to M&A strategy",
    "published": 1713256260,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "4 stocks to watch on Tuesday: JNJ, BAC and more",
    "published": 1713255600,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson says 'off to solid financial start' in 2024",
    "published": 1713254340,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Fly Intel: Pre-market Movers",
    "published": 1713253980,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson 2024 Q1 - Results - Earnings Call Presentation",
    "published": 1713253823,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson: EPS up to $2.20 in Q1",
    "published": 1713253234,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges",
    "published": 1713252420,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Balancing Act: Hold Rating on Johnson & Johnson Amid Steady Growth and Legal Challenges",
    "published": 1713251760,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Zimbabwe Issues Recall On Benylin Paediatric Syrup",
    "published": 1713251172,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Benylin Paediatric Syrup Banned",
    "published": 1713251172,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson 1Q Sales Rise on U.S. Growth, Cuts Adjusted EPS Outlook",
    "published": 1713250897,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "TOP NEWS: Johnson & Johnson upgrades guidance on swing to earnings",
    "published": 1713250440,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Earnings Turnaround For Johnson & Johnson With Q1 2024 Financial Results",
    "published": 1713250200,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson Raises Quarterly Dividend by 4.2% to $1.24",
    "published": 1713250167,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson : First Quarter 2024 1Q24 Other Financial Disclosures",
    "published": 1713249670,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Johnson & Johnson : 2024 First-Quarter Press Release & Supplemental Schedules",
    "published": 1713249547,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "JNJ Earnings: Johnson & Johnson\u2019s Q1 Earnings Beat Estimates",
    "published": 1713248940,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  },
  {
    "title": "Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break",
    "published": 1713248820,
    "posting_price": 140.50256703,
    "close_price": 139.9599762,
    "percent_change": -0.38617859
  }
]